NEW YORK (GenomeWeb News) — Hologic reported after the close of the market Monday a 6 percent increase in fiscal fourth quarter revenues, including a 14 percent spike in Diagnostics revenues driven primarily by the inclusion of a full quarter of Gen-Probe's sales.

For the three months ended Sept. 28, Hologic reported revenues of $622.1 million, up from $588.5 million in the same quarter last year, and falling short of the average Wall Street estimate of $624.4 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.